| # | Drug | Count |
|---|---|---|
| 0 | DARUNAVIR | 7 |
| 1 | RITONAVIR | 7 |
| 2 | DEXAMETHASONE | 5 |
| 3 | DEXAMETHASONE 1.5 MG | 5 |
| 4 | IBUPROFEN | 5 |
| 5 | LAMIVUDINE | 5 |
| 6 | LENALIDOMIDE | 5 |
| 7 | DARUNAVIR 600 MG | 3 |
| 8 | DARUNAVIR 800 MG | 3 |
| 9 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RALTEGRAVIR | 3 | 0.0006 |
| 1 | DARUNAVIR 600 MG | 3 | 0.0005 |
| 2 | NELFINAVIR MESYLATE | 1 | 0.0005 |
| 3 | DARUNAVIR | 7 | 0.0005 |
| 4 | MARAVIROC | 1 | 0.0004 |
| 5 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| 6 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 7 | LAMIVUDINE | 5 | 0.0002 |
| 8 | RITONAVIR 100 MG | 2 | 0.0001 |
| 9 | DOLUTEGRAVIR SODIUM | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 1 | Protease Inhibitor [EPC] | 8 | 0.0002 |
| 2 | Cytochrome P450 3A Inhibitor [EPC] | 8 | 0.0001 |
| 3 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0001 |
| 4 | Sulfone [EPC] | 1 | 0.0001 |
| 5 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 8 | 0.0001 |
| 6 | Androgen [EPC] | 1 | 0.0000 |
| 7 | Phenothiazine [EPC] | 1 | 0.0000 |
| 8 | Pyrimidine Synthesis Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Methylxanthine [EPC] | 1 | 0.0000 |